Invesco ltd: Form 8.3 - Allergan PLC

 | Source: Invesco ltd Invesco ltd

Form 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

  1. KEY INFORMATION
Name of person dealing (Note 1)Invesco Ltd.
Company dealt inAllergan PLC
Class of relevant security to which the dealings being disclosed relate (Note 2)Ordinary Shares IE00BY9D5467
Date of dealing28-06-2019
  1. INTERESTS AND SHORT POSITIONS
     
  2. Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
 LongShort
 Number (%)Number (%)
(1) Relevant securities3,232,795*   0.986%  
(2) Derivatives (other than options)  
(3) Options and agreements to purchase/sell  
Total3,232,795*   0.986%  

*The change of 7 shares in holdings since the previous disclosure filed on 28-06-2019 is due to the transfer out of a discretionary holding.

  1. Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security:LongShort
 Number (%)Number (%)
(1) Relevant securities  
 

(2) Derivatives (other than options)		  
 

(3) Options and agreements to purchase/sell		  
Total  


  1. DEALINGS (Note 4)
     
  2. Purchases and sales
 

Purchase/sale		 

Number of relevant securities		 

Price per unit (Note 5)
Sell85166.10 USD
Sell124,462167.32 USD
Sell6,480167.43 USD
Buy2,843167.43 USD
Buy143166.10 USD
Sell57 167.24 USD
  1. Derivatives transactions (other than options transactions)
Product name,

e.g. CFD		Nature of transaction

(Note 6)		Number of relevant securities

(Note 7)		Price per unit

(Note 5)
    
  1. Options transactions in respect of existing relevant securities
  1. Writing, selling, purchasing or varying
Product name,
e.g. call option		Writing, selling, purchasing, varying etc.Number of securities to which the option relates (Note 7)Exercise priceType, e.g. American, European etc.Expiry dateOption money paid/received per unit (Note 5)
       
  1. Exercising
Product name,

e.g. call option		Number of securitiesExercise price per unit (Note 5)
   
  1. Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction

(Note 8)		DetailsPrice per unit

(if applicable) (Note 5)
   


Is a Supplemental Form 8 attached? (Note 9)                                            YES/NO

Date of disclosure01-07-2019
Contact nameSam Edwards
Telephone number01491 416 381
If a connected EFM, name of offeree/offeror with which connectedN/A
If a connected EFM, state nature of connection (Note 10) 

GlobeNewswire